Alembic Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue1,5961,4221,5841,5021,808
Expenses1,4091,3181,4921,3761,591
EBITDA275.55195.29183.87221.53314.80
EBIT218.30125.60115.27148.16239.16
Profit Before Tax200.02103.8191.56125.52216.35
Net Profit165.7885.8175.34103.52179.36
Financial Ratios
Operating Profit Margin18.25%13.89%11.71%14.83%17.53%
Net Profit Margin9.81%6.10%4.80%6.93%9.99%
Earning Per Share (Diluted)8.434.373.835.279.12
Dividends Per Share0.000.000.000.000.00